Manufacturer's refund claim allowed due to lack of evidence of overcharging under unjust enrichment principle The Tribunal allowed the manufacturer's appeal against the rejection of a refund claim due to unjust enrichment. The appellant's practice of selling goods ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Manufacturer's refund claim allowed due to lack of evidence of overcharging under unjust enrichment principle
The Tribunal allowed the manufacturer's appeal against the rejection of a refund claim due to unjust enrichment. The appellant's practice of selling goods at MRP and paying duty post-abatement, coupled with fixed drug prices, led to the dismissal of the Revenue's claim. The Tribunal emphasized that unjust enrichment does not apply when products are sold at MRP without evidence of overcharging. As the Revenue failed to prove excess charges beyond MRP, the refund claim was allowed, overturning the initial rejection.
Issues: Refund claim rejection on grounds of unjust enrichment.
Analysis: The appellant, a manufacturer of bulk drugs, appealed against the rejection of a refund claim due to unjust enrichment. The appellant paid duty under Section 4(A) of the Central Excise Act, 1944, availing abatement prescribed by a notification. Despite an increase in payment from 40% to 42.5%, the appellant continued paying at the lower rate. The Revenue contended that the excess duty was passed on to customers, leading to unjust enrichment. The appellant argued that as prices were fixed by the drugs authority and goods sold at MRP, the duty burden was solely on them, citing precedents like M/s Gobind Sugar Mills Ltd. and M/s Dupen Laboratories Pvt. Ltd.
The Tribunal noted the undisputed practice of the appellant clearing goods at MRP and paying duty post-abatement. The Revenue's claim of unjust enrichment was dismissed based on the Dupen Laboratories Pvt. Ltd. case, which emphasized that unjust enrichment doesn't apply when products are sold at MRP unless there's evidence of overcharging. Since the drugs' prices were fixed, and the appellant only charged MRP, the duty burden fell on them alone. The Revenue failed to prove any excess charges beyond the MRP. Consequently, the Tribunal allowed the refund claim, setting aside the impugned order.
In conclusion, the appeal was allowed, granting consequential relief. The judgment highlighted the importance of fixed prices in determining unjust enrichment, emphasizing that in the absence of evidence of overcharging, the duty burden borne by the appellant alone negates the unjust enrichment argument.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.